FDA Issues Guidance for Combination Hypertension Drugs By Sam | December 13, 2018 The FDA released final guidance for sponsors of fixed-combination hypertension drugs, with several clarifications of the draft document. Source: International Pharmaceutical Regulatory Monitor Posted in International Pharmaceutical Regulatory Monitor